Price $8.39 |
Market Cap
1.27B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.07
|
P/S
0.29
|
Dividend %
-
|
|
P/CF
38.9
|
P/FCF
3.3
|
Op. Cash Flow
198.6K
|
FCF
1.2
|
|
Op. Margin
8.40%
|
Net Margin
-0.10%
|
ROE
-0.70%
|
ROI
-3.30%
|
|
ROA
-0.10%
|
EPS Growth
98.40%
|
Current Ratio
1.9
|
Debt/Equity
902.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| STRATA Skin Sciences Inc (SSKN) | $3.09 | - | - | 16.4M | Strong Buy |
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| Rockwell Medical Inc (RMTI) | $3.04 | - | - | 55M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $0.59 | - | - | 1.2M | Strong Buy |
| Omnicell Inc (OMCL) | $44.48 | - | - | 1.32B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
